Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.
- DOI
- 10.1038/s41591-024-02886-y
- Published
- 2024 Apr
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-024-02886-y,
title = {Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.},
author = {Pagano G and Taylor KI and Anzures Cabrera J and Simuni T and Marek K and Postuma RB and Pavese N and Stocchi F and Brockmann K and Svoboda H and Trundell D and Monnet A and Doody R and Fontoura P and Kerchner GA and Brundin P and Nikolcheva T and Bonni A and PASADENA Investigators and Prasinezumab Study Group},
year = {2024},
journal = {Nature medicine},
doi = {10.1038/s41591-024-02886-y},
url = {https://doi.org/10.1038/s41591-024-02886-y}
}RIS
TY - JOUR TI - Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease. AU - Pagano G AU - Taylor KI AU - Anzures Cabrera J AU - Simuni T AU - Marek K AU - Postuma RB AU - Pavese N AU - Stocchi F AU - Brockmann K AU - Svoboda H AU - Trundell D AU - Monnet A AU - Doody R AU - Fontoura P AU - Kerchner GA AU - Brundin P AU - Nikolcheva T AU - Bonni A AU - PASADENA Investigators AU - Prasinezumab Study Group PY - 2024 JO - Nature medicine DO - 10.1038/s41591-024-02886-y UR - https://doi.org/10.1038/s41591-024-02886-y ER -
APA
G, P., KI, T., J, A. C., T, S., K, M., RB, P., N, P., F, S., K, B., H, S., D, T., A, M., R, D., P, F., GA, K., P, B., T, N., A, B., Investigators, P., & Group, P. S. (2024). Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease.. Nature medicine. https://doi.org/10.1038/s41591-024-02886-y
Source records
- pubmed · retrieved 2026-09-27T14:16:27.010Z